LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

REBECA trial: a new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer

Photo from wikipedia

Lee et al . (1) evaluated the efficacy and safety of bevacizumab in combination with single-agent chemotherapy for platinum-resistant ovarian cancer in a large retrospective analysis involving Korean women with… Click to show full abstract

Lee et al . (1) evaluated the efficacy and safety of bevacizumab in combination with single-agent chemotherapy for platinum-resistant ovarian cancer in a large retrospective analysis involving Korean women with platinum-resistant recurrent ovarian cancer from 27 different institutions.

Keywords: bevacizumab; resistant recurrent; ovarian cancer; platinum resistant; recurrent ovarian; cancer

Journal Title: Translational cancer research
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.